Replies to post #112939 on OWC Pharmaceutical Research Corp (OWCP)

[happpytrader]

I'm gonna go ahead and call BS on that. Not that I care at all about what GWPH is doing since I'm long here on OWCP, but, a quick search of GW's financials shows 206 revenues of 10,315,000 GBP. So let's not say incorrect things like this and let's not compare apples to oranges. There is a reason it trades at 100 something, because its value can also be a multiple of its EBITDA, something that we don't have YET...

[I-Glow]

Comparing OWCP to GW Pharmaceuticals is comical - they have at least 40 cannabis related patents - dozens more in the pipeline.

And GWP also has revenue.

Here are some facts about GWP:

"GW Pharmaceuticals Receives FDA Fast Track and EMA Orphan Designations for Intravenous Cannabidiol in the Treatment of Neonatal Hypoxic-Ischemic Encephalopathy (NHIE)"

"GW Pharmaceuticals Announces Epidiolex® Receives Fast Track Designation from FDA for the Treatment of Dravet Syndrome"

GWP is doing FDA approved clinical trials on Epidiolex and Sativex. Here is a list of the GWP Clinical Trials: https://www.gwpharm.com/products-pipeline/pipeline

Here is a partial list of published research: https://www.gwpharm.com/products-pipeline/research-trials/research-papers

There isn't any comparison between OWCP and a real company like GWP.

IG